Zura Bio Limited Warrants
ZURAW
ZURAW was delisted on the 27th of August, 2024.
13 hedge funds and large institutions have $493K invested in Zura Bio Limited Warrants in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
7% less funds holding
Funds holding: 14 → 13 (-1)
20% less capital invested
Capital invested by funds: $619K → $493K (-$126K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$59.1K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$22.1K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$9.74K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$878 |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$596 |
ZURAW Hedge Fund Activity: Q1 2024 in Review
13 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Zura Bio Limited Warrants (ZURAW) for Q1 2024, worth a combined $493K — down 20% from $619K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ZURAW and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.
The largest seller was Boothbay Fund Management, exiting entirely with an estimated $59.1K sold.
- 13 institutional investors held Zura Bio Limited Warrants (ZURAW) as of Q1 2024, down from 14 in Q4 2023.
- Funds reported $493K of Zura Bio Limited Warrants stock for Q1 2024, down 20% quarter-over-quarter.
- 0 funds opened new Zura Bio Limited Warrants positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Zura Bio Limited Warrants seller in Q1 2024 was Boothbay Fund Management, an estimated $59.1K sold.
Based on aggregated 13F filings for Q1 2024.